Aka. RiaSTAP or Fibrinogen (Factor I) Concentrate DESCRIPTION INDICATIONS ADMINISTRATION / DOSING Intravenous (IV) PREPARATION PHARMACEUTICS GROUP / CROSSMATCH ADVERSE EFFECTS LOCATION OF ACTION MECHANISM OF ACTION CONTRAINDICATIONS ADVANTAGES AND DISADVANTAGES TO CRYOPRECIPITATE Advantages Disadvantages RECONSTITUTION TIPS It is a…